Raimondo Cau

About

Raimondo Cau is a pioneering figure in the field of reconstructive microsurgery, with a focus on developing and validating robotic systems for supermicrosurgery—a technique involving the connection of blood vessels and lymphatic channels as small as 0.3 to 0.8 mm. His major contributions center on the creation of the first dedicated robotic platform for microsurgery, designed to overcome the inherent limitations of human precision and dexterity in these delicate procedures. Cau’s landmark work includes the first-in-human randomized pilot trial (194 citations) demonstrating the use of a dedicated microsurgical robot for treating breast cancer-related lymphedema, a study that has significantly influenced clinical practice. His preclinical and feasibility studies (77 and 67 citations, respectively) established the foundational evidence for robotic (super)microsurgery, showcasing its potential to improve surgical outcomes and ergonomics. Cau’s research has been instrumental in advancing the integration of robotics into reconstructive surgery, with his work cited over 350 times, reflecting its substantial impact on the field.

Research Focus

Key Achievements

Top Papers

1. 1
   First-in-human robotic supermicrosurgery using a dedicated microsurgical robot for treating breast cancer-related lymphedema: a randomized pilot trial

   194 citations · 2020
2. 2
   Preclinical Experience Using a New Robotic System Created for Microsurgery

   77 citations · 2018
3. 3
   Robotic (super) microsurgery: Feasibility of a new master‐slave platform in an in vivo animal model and future directions

   67 citations · 2018
4. 4
   The journey of creating the first dedicated platform for robot-assisted (super)microsurgery in reconstructive surgery

   17 citations · 2019
5. 5
   A Dedicated Robotic System for Open (Super-)Microsurgery

   3 citations · 2021

Key Collaborators

Contact & Links